Fundraising Foxdievini Hopp BioTech holding GmbH & Co. KG
Venture capital1 people tracked
Find your way into dievini Hopp BioTech holding GmbH & Co. KG
Sign up to see every warm intro you have to dievini Hopp BioTech holding GmbH & Co. KG
- Paths you didn't know you had: your email and LinkedIn already hold routes to the dievini Hopp BioTech holding GmbH & Co. KG team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
dievini backs life and health sciences companies pursuing novel therapeutic and diagnostic approaches with the potential to enable entirely new treatment forms, aiming to give physicians and patients more effective and better-tolerated therapies in mostly life-threatening indications. Portfolio companies focus on oncology, plus neurology, infectious diseases, cell therapy and improved drug formulation. In molecular diagnostics, the emphasis is on personalized-medicine systems and products that improve individual therapy outcomes while reducing side effects. Geographically, dievini concentrates on Germany and Europe while supporting companies in their global development and commercialization.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's website
Frequently asked questions
- What sectors does dievini Hopp BioTech holding GmbH & Co. KG focus on?
- dievini Hopp BioTech holding GmbH & Co. KG focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Sector Agnostic.
Similar investors
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Blackstone is one of the world's largest alternative investment firms, managing over $1.3 trillion across private equity, real estate, credit and insurance, multi-asset investing, infrastructure, and life sciences. Blackstone Life Sciences is the firm's dedicated life sciences investing business.
ARCHIMED is a global investment firm focused exclusively on the healthcare industries, partnering with companies to support their next growth phase through internationalization, innovation and M&A.
Patient Square Capital is a health care-focused investment firm that partners with management teams building products, services, and technologies that improve health, investing across the health care sector's subsectors.